• This article examines whether Ingredion stock at around US$100 reflects excessive pessimism or potential value that the market may be overlooking, with a focus on what the current share price might imply.
• Ingredion's share price closed at US$100.34 after declining 6.0% over the past week, 12.9% over the past month, 8.6% year to date, and 26.8% over the last year. These moves may have influenced how investors view both its opportunity and risk.
• Recent news coverage has focused on Ingredion's positioning in the global ingredients market, including how it serves food, beverage and industrial customers as demand for specialty ingredients evolves. Commentary has also highlighted the stock's longer term 3-year and 5-year returns of a 1.3% decline and a 21.1% gain respectively, which provides additional context for the recent share price weakness.
• Against that backdrop, Ingredion currently has a valuation score of 6 out of 6. The remainder of this article will outline what different valuation approaches indicate about the stock, while reserving one more powerful way of thinking about value for the end.

Approach 1: Ingredion Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of future cash that a company may generate, then discounts those cash flows back to today to arrive at an estimate of what the business could be worth now.

For Ingredion, the model used is a 2 Stage Free Cash Flow to Equity framework. The latest twelve month Free Cash Flow is about US$554.6 million. Simply Wall St uses analyst inputs where available, then extends those projections further out. For example, the ten year path includes forecast Free Cash Flow of US$436 million in 2026 and US$602.9 million in 2035, with US$516 million in 2028 specifically highlighted in the dataset.

Bringing all those projected cash flows back to today results in an estimated intrinsic value of about US$197.82 per share, compared with the recent share price of about US$100.34. On this basis, the DCF output suggests the stock is about 49.3% below that intrinsic estimate, which points to it being undervalued on these assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Ingredion is undervalued by 49.3%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks.

Approach 2: Ingredion Price vs Earnings

For profitable companies, the P/E ratio is a useful way to see how much you are paying for each dollar of current earnings. A higher or lower P/E often reflects what the market expects for future growth and how much risk investors see in those earnings.

In general, stronger expected growth and lower perceived risk tend to support a higher, or "normal," P/E ratio, while slower growth or higher risk usually line up with a lower one. Ingredion currently trades on a P/E of about 9.4x. That is below the Food industry average of about 18.4x and well below the peer group average of about 33.7x.

Simply Wall St also calculates a proprietary "Fair Ratio" for each stock. For Ingredion, this Fair Ratio is 16.8x. It is designed to be more tailored than a simple industry or peer comparison because it factors in elements such as earnings growth, profit margins, risk profile, industry, and market capitalization. By comparing the current P/E of 9.4x with the Fair Ratio of 16.8x, the stock screens as undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Ingredion Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so consider Narratives, which are simple stories you build around a company that connect your view of its future revenue, earnings and margins to a fair value, then compare that fair value with the current price to help you decide if, when and how much to invest or trim.

On Simply Wall St, Narratives sit inside the Community page and are designed to be accessible, so you can take the same core data millions of other investors see and quickly plug in your own assumptions rather than relying only on headline ratios.

Each Narrative stays live and updates when fresh news, earnings or guidance arrives, so your fair value view adjusts alongside the information instead of staying frozen at the moment you built it.

For Ingredion, for example, one investor might lean closer to the higher analyst price target of US$140 if they think health and affordability trends and cost efficiencies will support the analyst forecast that earnings could reach US$787.8 million by about May 2029. Another investor might anchor on the lower US$110 target if they focus more on risks around global trade, legacy product demand and site specific issues that analysts link to a slightly lower fair value of about US$121.86 today.

Do you think there's more to the story for Ingredion? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.